Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Net Income (2016 - 2025)

Historic Net Income for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's Net Income rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 707.61%. This contributed to the annual value of -$39.3 million for FY2024, which is 632.44% up from last year.
  • As of Q3 2025, Jaguar Health's Net Income stood at -$9.6 million, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Net Income peaked at -$7.9 million during Q3 2023, and registered a low of -$18.2 million during Q1 2022.
  • In the last 5 years, Jaguar Health's Net Income had a median value of -$10.6 million in 2025 and averaged -$11.2 million.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 6327.97% in 2021, then surged by 4250.59% in 2022.
  • Jaguar Health's Net Income (Quarter) stood at -$14.3 million in 2021, then surged by 42.51% to -$8.2 million in 2022, then decreased by 13.08% to -$9.3 million in 2023, then dropped by 9.94% to -$10.2 million in 2024, then rose by 5.73% to -$9.6 million in 2025.
  • Its last three reported values are -$9.6 million in Q3 2025, -$10.6 million for Q2 2025, and -$10.6 million during Q1 2025.